Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon May 26, 2011 12:55am
243 Views
Post# 18626905

RE: RE: The defence rests..........

RE: RE: The defence rests..........Ohh, my, as much as someguy is a stalwart SDI guy, he does provide an interesting insights although I haven't quite figured out all the ins and outs of them. The company is the problem, imo. Not sure how they can get the word out when the trial is not finished. Partial/interim updates can't be done imo without tainting the tape. Of course, those that have benefited from the financing and have an inside track, probably know a lot more than we the minor shareholders. That's the problem with the market. Rich man's game but I'm willing to hold so maybe I could become a rich man (monetarily-more than my meagre yearly salary would make me feel that way).
As much as I am tired of waiting, I don't think there will be any news for at least another 6 months, either way. Would love to see the SDI make the FDA realize the efficacy of the product like in other countries, as stated earlier but .... So waiting, impatiently.
Bullboard Posts